Flo Health Study on Endometriosis Symptom Checker
Analysis based on 9 articles · First reported Mar 02, 2026 · Last updated Mar 04, 2026
The publication of this study by Flo Health is expected to positively impact the digital health market, particularly in women's health, by demonstrating the economic and health benefits of digital symptom checkers. This could lead to increased adoption of such tools and potentially influence investment in femtech companies like Flo Health.
Flo Health, the leading women's health app, announced the publication of a peer-reviewed study in Npj Digital Medicine. The study, conducted in partnership with London School of Hygiene & Tropical Medicine and the York Health Economic Consortium, is the first economic evaluation of a digital symptom checker for endometriosis. It found that Flo Health's Symptom Checker could reduce the average time to endometriosis diagnosis from seven years to three years, cut medical costs, and generate a net monetary benefit of nearly $10,100 per patient. This research highlights the significant financial and health benefits of digital health technology in addressing diagnostic delays for conditions like endometriosis, which affects approximately 190 million women globally. Dr. Anna Klepchukova, Chief Medical Officer at Flo Health, emphasized that these tools empower women and provide clearer insights for healthcare providers. Flo Health, which became the first European femtech unicorn after a July 2024 investment from General Atlantic, supports 77 million monthly active users.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard